Vitamin D: a link between Epstein–Barr virus and multiple sclerosis development?

References

• Ramagopalan SV, Dobson R, Meier UC, Giovannoni G. Multiple sclerosis: risk factors, prodromes, and potential causal pathways. Lancet Neurol.9(7), 727–739 (2010).
   PubMed Web of Science ®Google Scholar
• Ebers GC. Environmental factors and multiple sclerosis. Lancet Neurol.7(3), 268–277 (2008).
   PubMed Web of Science ®Google Scholar
• Simpson S Jr, Blizzard L, Otahal P, Van Der Mei I, Taylor B. Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis. J. Neurol. Neurosurg. Psychiatry DOI: 10.1136/jnnp.2011.240432 (2011) (Epub ahead of print).
   Google Scholar
• Ramagopalan SV, Handel AE, Giovannoni G, Rutherford Siegel S, Ebers GC, Chaplin G. Relationship of UV exposure to prevalence of multiple sclerosis in England. Neurology76(16), 1410–1414 (2011).
   PubMed Web of Science ®Google Scholar
• Munger Kl, Zhang SM, O’Reilly E et al. Vitamin D intake and incidence of multiple sclerosis. Neurology62(1), 60–65 (2004).
   PubMed Web of Science ®Google Scholar
• Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA296(23), 2832–2838 (2006).
   PubMed Web of Science ®Google Scholar
• Anzgene. Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20. Nat. Genet.41(7), 824–828 (2009).
   PubMed Web of Science ®Google Scholar
• Simpson S Jr, Taylor B, Blizzard L et al. Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis. Ann. Neurol.68(2), 193–203 (2010).
   PubMed Web of Science ®Google Scholar
• Walker VP, Modlin RL. The vitamin D connection to pediatric infections and immune function. Pediatr. Res.65(5 Pt 2), 106R–113R (2009).
   PubMed Web of Science ®Google Scholar
• Kamen DL, Tangpricha V. Vitamin D and molecular actions on the immune system: modulation of innate and autoimmunity. J. Mol. Med.88(5), 441–450 (2010).
   PubMed Web of Science ®Google Scholar
• Ramagopalan SV, Heger A, Berlanga AJ et al. A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution. Genome Res.20(10), 1352–1360 (2010).
   PubMed Web of Science ®Google Scholar
• Ascherio A, Munger Kl. Epstein–Barr virus infection and multiple sclerosis: a review. J. Neuroimmune Pharmacol.5(3), 271–277 (2010).
   PubMed Web of Science ®Google Scholar
• Ascherio A, Munger Kl. Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann. Neurol.61(4), 288–299 (2007).
   PubMed Web of Science ®Google Scholar
• Ramagopalan SV, Meier UC, Conacher M et al. Role of the HLA system in the association between multiple sclerosis and infectious mononucleosis. Arch. Neurol.68(4), 469–472 (2011).
   Google Scholar
• Banwell B, Bar-Or A, Arnold Dl et al. Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study. Lancet Neurol.10(5), 436–445 (2011).
   PubMed Web of Science ®Google Scholar
• Holick MF. Vitamin D deficiency. N. Engl. J. Med.357(3), 266–281 (2007).
   PubMed Web of Science ®Google Scholar
• Smolders J, Thewissen M, Peelen E et al. Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis. PLoS One4(8), e6635 (2009).
   PubMed Web of Science ®Google Scholar
• Wingate PJ, McAulay KA, Anthony IC, Crawford DH. Regulatory T cell activity in primary and persistent Epstein–Barr virus infection. J. Med. Virol.81(5), 870–877 (2009).
   PubMed Web of Science ®Google Scholar
• Handel AE, Giovannoni G, Ebers GC, Ramagopalan SV. Environmental factors and their timing in adult-onset multiple sclerosis. Nat. Rev. Neurol.6(3), 156–166 (2010).
   PubMed Web of Science ®Google Scholar
• Zwart SR, Mehta SK, Ploutz-Snyder R et al. Response to vitamin D supplementation during Antarctic winter is related to BMI, and supplementation can mitigate Epstein–Barr virus reactivation. J. Nutr.141(4), 692–697 (2011).
   PubMed Web of Science ®Google Scholar
• Yenamandra SP, Hellman U, Kempkes B et al. Epstein–Barr virus encoded EBNA-3 binds to vitamin D receptor and blocks activation of its target genes. Cell Mol. Life Sci.67(24), 4249–4256 (2010).
   PubMed Web of Science ®Google Scholar
• Hertle ML, Popp C, Petermann S et al. Differential gene expression patterns of EBV infected EBNA-3A positive and negative human B lymphocytes. PLoS Pathog.5(7), e1000506 (2009).
   Google Scholar
• Means RE, Lang SM, Jung JU. Human γ-herpesvirus immune evasion strategies. In: Human Herpesviruses: Biology, Therapy and Immunoprophylaxis. Arvin A, Campadelli-Fiume G, Mocarski E et al. (Eds). Cambridge University Press, Cambridge, UK (2007).
   Google Scholar
• Beard JA, Bearden A, Striker R. Vitamin D and the anti-viral state. J. Clin. Virol.50(3), 194–200 (2011).
   PubMed Web of Science ®Google Scholar
• Cannell JJ, Vieth R, Umhau JC et al. Epidemic influenza and vitamin D. Epidemiol. Infect.134(6), 1129–1140 (2006).
   PubMed Web of Science ®Google Scholar
• Aloia JF, Li-Ng M. Re: epidemic influenza and vitamin D. Epidemiol. Infect.135(7), 1095–1096; author reply 1097–1098 (2007).
   PubMed Web of Science ®Google Scholar
• Bar-Or A, Fawaz L, Fan B et al. Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS? Ann. Neurol.67(4), 452–461 (2010).
   PubMed Web of Science ®Google Scholar
• Khademi M, Kockum I, Andersson ML et al. Cerebrospinal fluid CXCL13 in multiple sclerosis: a suggestive prognostic marker for the disease course. Mult. Scler.17(3), 335–343 (2011).
   PubMed Web of Science ®Google Scholar
• Kakalacheva K, Lunemann JD. Environmental triggers of multiple sclerosis. FEBS Lett. DOI: 10.1016/j.febslet.2011.04.006 (2011) (Epub ahead of print).
   Google Scholar